a public good project by the
Synthesis
Company
of California

© 2026

Hideo Shigematsu | doi.page

0 works0 citations0 h-index

Hideo Shigematsu

Hiroshima University(JP)Showa University Northern Yokohama Hospital(JP)Hiroshima University Hospital(JP)

Publications by Year

Research Areas

Breast Cancer Treatment Studies, Epilepsy research and treatment, Breast Lesions and Carcinomas, Cancer Treatment and Pharmacology, HER2/EGFR in Cancer Research

Most-Cited Works

→ Ambroxol chaperone therapy for neuronopathic Gaucher disease: A pilot study(2016)213 cited
→ Long‐term course of Dravet syndrome: A study from an epilepsy center in Japan(2014)83 cited
→ Utility of 18F FDG-PET/CT for predicting prognosis of luminal-type breast cancer(2015)69 cited
→ Cryotherapy for the prevention of weekly paclitaxel-induced peripheral adverse events in breast cancer patients(2020)60 cited
→ An Analytic Study of Epileptic Falls(1985)57 cited
→ Ability of contrast-enhanced ultrasonography to determine clinical responses of breast cancer to neoadjuvant chemotherapy(2016)51 cited

→ Ipsilateral breast tumor recurrence (IBTR) in patients with operable breast cancer who undergo breast‐conserving treatment after receiving neoadjuvant chemotherapy(2012)

44 cited

→ Role of FDG-PET/CT in evaluating surgical outcomes of operable breast cancer – Usefulness for malignant grade of triple-negative breast cancer(2013)44 cited

→ The ratio of CD8 + lymphocytes to tumor-infiltrating suppressive FOXP3 + effector regulatory T cells is associated with treatment response in invasive breast cancer(2022)39 cited

→ Rapamycin enhances chemotherapy‐induced cytotoxicity by inhibiting the expressions of TS and ERK in gastric cancer cells(2009)36 cited